Left ventricular remodeling and hypertrophy in patients with aortic stenosis: Insights from cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Dweck, Marc R ^a,b   Joshi, Sanjiv ^a   Murigu, Timothy ^a   Gulati, Ankur ^a,c   Alpendurada, Francisco ^a   Jabbour, Andrew ^a   MacEira, Alicia ^a   Roussin, Isabelle ^a   Northridge, David B ^b   Kilner, Philip J ^a,c   Cook, Stuart A ^a,c   Boon, Nicholas A ^b   Pepper, John ^a,c   Mohiaddin, Raad H ^a,c   Newby, David E ^b   Pennell, Dudley J ^a,c   Prasad, Sanjay K ^a,c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aortic valve disease; Cardiac remodeling; MRI

Indexed keywords

ADULT; AGED; AORTA STENOSIS; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; AORTIC VALVE STENOSIS; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84864189092     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-50     Document Type: Article

References (32)

1. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease. Carabello BA, J Heart Valve Dis 1995 4 Suppl 2 132 S138 discussion S138-139 8563989
2. Wall stress and patterns of hypertrophy in the human left ventricle. Grossman W, Jones D, McLaurin L, J Clin Invest 1975 56 56 64 10.1172/JCI108079 124746
3. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Gradman AH, Alfayoumi F, Prog Cardiovasc Dis 2006 48 326 341 10.1016/j.pcad.2006.02.001 16627048
4. Left ventricular hypertrophy as a predictor of cardiovascular risk. Gosse P, J Hypertens Suppl 2005 23 27 S33 10.1097/01.hjh.0000165625.79933.9a 15821448
5. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E, de Simone G, Heart 2011 97 301 307 10.1136/hrt.2010.192997 20720251
6. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH, J Am Coll Cardiol 1992 19 1550 1558 10.1016/0735-1097(92)90617-V 1534335
7. Comparison of left ventricular geometry and left atrial size and function in patients with aortic stenosis versus those with pure aortic regurgitation. Cioffi G, Stefenelli C, Am J Cardiol 2002 90 601 606 10.1016/S0002-9149(02) 02563-8 12231084
8. Asymmetric septal hypertrophy in patients with aortic stenosis: an adaptive mechanism or a coexistence of hypertrophic cardiomyopathy? Hess OM, Schneider J, Turina M, Carroll JD, Rothlin M, Krayenbuehl HP, J Am Coll Cardiol 1983 1 783 789 10.1016/S0735-1097(83)80191-0 6681825
9. Asymmetric septal hypertrophy-a marker of hypertension in aortic stenosis (a SEAS substudy). Tuseth N, Cramariuc D, Rieck AE, Wachtell K, Gerdts E, Blood Press 2010 19 140 144 10.3109/08037051.2010.481816 20429691
10. Hypertrophic cardiomyopathy phenotype revisited after 50years with cardiovascular magnetic resonance. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E, J Am Coll Cardiol 2009 54 220 228 10.1016/j.jacc.2009.05.006 19589434
11. Assessment of left ventricular mass by cardiovascular magnetic resonance. Myerson SG, Bellenger NG, Pennell DJ, Hypertension 2002 39 750 755 10.1161/hy0302.104674 11897757
12. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? John AS, Dill T, Brandt RR, Rau M, Ricken W, Bachmann G, Hamm CW, J Am Coll Cardiol 2003 42 519 526 10.1016/S0735-1097(03)00707-1 12906983
13. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. Maceira AM, Prasad SK, Khan M, Pennell DJ, J Cardiovasc Magn Reson 2006 8 417 426 10.1080/ 10976640600572889 16755827
14. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441
15. Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis). Rodriguez CJ, Diez-Roux AV, Moran A, Jin Z, Kronmal RA, Lima J, Homma S, Bluemke DA, Barr RG, J Am Coll Cardiol 2010 55 234 242 10.1016/j.jacc.2009.08.046 20117402
16. Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. Buchner S, Debl K, Haimerl J, Djavidani B, Poschenrieder F, Feuerbach S, Riegger GA, Luchner A, J Cardiovasc Magn Reson 2009 11 18 10.1186/1532-429X-11-18 19486532
17. Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. Lamb HJ, Beyerbacht HP, de Roos A, van der Laarse A, Vliegen HW, Leujes F, Bax JJ, van der Wall EE, J Am Coll Cardiol 2002 40 2182 2188 10.1016/S0735-1097(02)02604-9 12505232
18. Determinants of left ventricular hypertrophy in patients with aortic stenosis. Salcedo EE, Korzick DH, Currie PJ, Stewart WJ, Lever HM, Goormastic M, Cleve Clin J Med 1989 56 590 596 2530009
19. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Kupari M, Turto H, Lommi J, Eur Heart J 2005 26 1790 1796 10.1093/eurheartj/ehi290 15860517
20. Determinants of ventricular function in pressure-overload hypertrophy in man. Gunther S, Grossman W, Circulation 1979 59 679 688 10.1161/01.CIR.59.4.679 154367
21. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ, N Engl J Med 2000 342 1778 1785 10.1056/NEJM200006153422403 10853000
22. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, Banya W, Gulati A, Roussin I, Raza S, et al. J Am Coll Cardiol 2011 58 1271 1279 10.1016/j.jacc.2011.03.064 21903062
23. Influence of ACE I/D genotypes on left ventricular hypertrophy in aortic stenosis: gender-related differences. Orlowska-Baranowska E, Placha G, Gaciong Z, Baranowski R, Zakrzewski D, Michalek P, Hoffman P, Rawczynska-Englert I, J Heart Valve Dis 2004 13 574 581 15311863
24. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB, Circulation 1992 86 1099 1107 10.1161/01.CIR.86.4.1099 1394918
25. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). Rieck AE, Cramariuc D, Staal EM, Rossebo AB, Wachtell K, Gerdts E, J Hypertens 2010 28 377 383 10.1097/HJH.0b013e328332fa44 19844185
26. Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training. Montgomery HE, Clarkson P, Dollery C, Prasad K, Losi MA, Circulation 1997 96 741 747 10.1161/01.CIR.96.3.741 9264477
27. Genetic determinants of cardiac hypertrophy. Marian AJ, Curr Opin Cardiol 2008 115 199 205
28. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, Mangion J, Schroen B, Benson M, Punjabi PP, et al. Nat Genet 2008 40 546 552 10.1038/ng.134 18443592
29. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Dellgren G, Eriksson MJ, Blange I, Brodin LA, Radegran K, Sylven C, Am J Cardiol 1999 84 909 913 10.1016/S0002-9149(99)00464-6 10532509
30. ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, et al. J Am Coll Cardiol 2011 2011 58 212 e260
31. Mechanism of development of asymmetric septal hypertrophy in patients with essential systemic hypertension. Yokota Y, Teng SS, Emoto R, Miki T, Takarada A, Seo T, Sano H, Fukuzaki H, Jpn Circ J 1989 53 1173 1184 10.1253/jcj.53.1173 2533275
32. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Lund O, Flo C, Jensen FT, Emmertsen K, Nielsen TT, Rasmussen BS, Hansen OK, Pilegaard HK, Kristensen LH, Eur Heart J 1997 18 1977 1987 10.1093/oxfordjournals.eurheartj. a015209 9447328